Trinity Biotech (TRIB) Invested Capital (2009 - 2025)

Trinity Biotech has reported Invested Capital for 15 years, with the latest figure at $13.4 million in Q4 2025.

• Quarterly Invested Capital rose 5.22% year-over-year to $13.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $109.8 million (up 39.79% YoY) and the FY2025 annual result came in at $13.4 million, up 5.22% from the prior year.
• Invested Capital declined to $13.4 million in Q4 2025 per TRIB's latest filing, from $83.6 million in the prior quarter.
• Over five years, Invested Capital peaked at $224.8 million in Q4 2021 and troughed at -$210000.0 in Q2 2022.
• A 5-year average of $72.5 million and a median of $60.6 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2024 and 2025: Invested Capital sank 76.96% in 2024, then climbed 27.1% in 2025.
• Over 5 years, Invested Capital stood at $224.8 million in 2021, then plunged by 44.7% to $124.3 million in 2022, then slumped by 55.45% to $55.4 million in 2023, then tumbled by 76.96% to $12.8 million in 2024, then climbed by 5.22% to $13.4 million in 2025.
• According to Business Quant data, Invested Capital over the past three periods registered $13.4 million, $83.6 million, and $12.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.